Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhenbing Koukuining Lozenge in Recurrent Aphthous Ulcer
CTR20180834Phase 2Completed
- Sponsor
- Wuhan Junan Pharmaceutical
- Start
- Jul 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Zhenbing Koukuining lozenge in aphthosis (RAS), sponsored by Wuhan Junan Pharmaceutical. Started Jul 2018; status: completed.
02
Drugs
Zhenbing Koukuining lozenge
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on CTR20180834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180834.